Last reviewed · How we verify

NCT04929925

The Role of Serum Procalcitonin in Diagnosis and Detection of Outcome of Acute Bacterial Meningitis in Childern

Status unknown Last updated 18 June 2021
What this trial tests

trial testing serum procalcitonin in acute bacterial meningitis in CNS Infection in Children in 100 participants. Status unknown.

Timeline
15 June 2021
Primary endpoint
15 July 2022
15 July 2022

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date15 June 2021
Primary completion15 July 2022
Estimated completion15 July 2022

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 1 Month to 14, any sex, with CNS Infection in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Meningitis is one of the most common central nervous system (CNS) infections encountered in infants and children. The source of infection in meningitis can be bacterial, viral, fungal, or parasitic in origin . Bacterial meningitis is a paediatric emergency with high mortality and morbidity rate. Hence it must be diagnosed and treated promptly. But the similar clinical presentation often makes it difficult to differentiate bacterial and non-bacterial aetiologies in children .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04929925.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing